Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response

被引:385
作者
Boykoff, Nelli [2 ]
Moieni, Mona
Subramanian, Saskia Karen [1 ]
机构
[1] Univ Calif Los Angeles, UCLA Ctr Culture & Hlth, Semel Inst, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA
[2] Mayo Clin & Mayo Fdn, Mayo Med Sch, Rochester, MN 55905 USA
关键词
Breast cancer survivor; Chemobrain; Chemotherapy effects; Cognitive impairment; Psychosocial; Qualitative; RECEIVING ADJUVANT CHEMOTHERAPY; BREAST-CANCER; COGNITIVE FUNCTION; WOMEN; THERAPY; BRAIN;
D O I
10.1007/s11764-009-0098-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Mild cognitive impairment following chemotherapy is one of the most commonly reported post treatment symptoms by breast cancer survivors. This deterioration in cognitive function, commonly referred to as "chemobrain" or "chemofog," was largely unacknowledged by the medical community until recent years. Although chemobrain has now become the subject of more vigorous exploration, little is known about this specific phenomenon's psychosocial impact on breast cancer survivors. This research documents in-depth the effects that cognitive impairment has on women's personal and professional lives, and our data suggest that greater attention needs to be focused on this arena of survivorship. Methods The results are based on an in-depth qualitative study of 74 white and African American breast cancer survivors in California who experience post-treatment side effects. The data reported herein were obtained through the use of focus groups and in-depth interviews. Results Our data indicate that cognitive impairment can be problematic for survivors, with many asserting that it is their most troublesome post treatment symptom. Survivors report diminished quality of life and daily functioning as a result of chemobrain. Respondents detail a range of coping strategies that they are forced to employ in order to manage their social and professional lives. Discussions/conclusions Chemobrain significantly impairs a proportion of cancer survivors, at great cost to them economically, emotionally, and interpersonally. This suggests that more research needs to be conducted on the psychosocial ramifications of post treatment symptoms in order to inform the efforts of the medical and mental health communities as well as the support networks of survivors. Implications for cancer survivors A better and broader understanding of the effects of cognitive impairment both in the medical community and among lay people could pave the way for improved social and psychological services for this population.
引用
收藏
页码:223 / 232
页数:10
相关论文
共 34 条
[1]   Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma [J].
Ahles, TA ;
Saykin, AJ ;
Furstenberg, CT ;
Cole, B ;
Mott, LA ;
Skalla, K ;
Whedon, MB ;
Bivens, S ;
Mitchell, T ;
Greenberg, ER ;
Silberfarb, PM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :485-493
[2]  
[Anonymous], 2009, DET GUID BREAST CANC
[3]   Cognitive impairment associated with adjuvant therapy in breast cancer [J].
Bender, Catherine M. ;
Sereika, Susan M. ;
Berga, Sarah L. ;
Vogel, Victor G. ;
Brufsky, Adam M. ;
Paraskar, Karen K. ;
Ryan, Christopher M. .
PSYCHO-ONCOLOGY, 2006, 15 (05) :422-430
[4]   Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: A critical review [J].
Bender, CM ;
Paraska, KK ;
Sereika, SM ;
Ryan, CM ;
Berga, SL .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2001, 21 (05) :407-424
[5]   Cognitive function in breast cancer patients receiving adjuvant chemotherapy [J].
Brezden, CB ;
Phillips, KA ;
Abdolell, M ;
Bunston, T ;
Tannock, IF .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) :2695-2701
[6]   Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen [J].
Castellon, SA ;
Ganz, PA ;
Bower, JE ;
Petersen, L ;
Abraham, L ;
Greendale, GA .
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2004, 26 (07) :955-969
[7]  
Crabtree B.F., 1992, Doing Qualitative Research
[8]   Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma [J].
Donovan, KA ;
Small, BJ ;
Andrykowski, MA ;
Schmitt, FA ;
Munster, P ;
Jacobsen, PB .
CANCER, 2005, 104 (11) :2499-2507
[9]   Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy:: Evaluation with patient interview after formal assessment [J].
Downie, Fiona P. ;
Fan, Helen G. Mar ;
Houede-Tchen, Nadine ;
Yi, Qilong ;
Tannock, Ian F. .
PSYCHO-ONCOLOGY, 2006, 15 (10) :921-930
[10]   The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature [J].
Falleti, MG ;
Sanfilippo, A ;
Maruff, P ;
Weih, LA ;
Phillips, KA .
BRAIN AND COGNITION, 2005, 59 (01) :60-70